Market Research Logo

United States Interventional Neuroradiology Market Outlook to 2025

United States Interventional Neuroradiology Market Outlook to 2025

Summary

GlobalData’s new report, United States Interventional Neuroradiology Market Outlook to 2025, provides key market data on the United States Interventional Neuroradiology market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Intracranial Stents, Neurovascular Accessory Devices, Neurovascular Coiling Assist Devices, Neurovascular Embolization Devices and Neurovascular Thrombectomy Devices.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size and company share data for Interventional Neuroradiology market segments - Intracranial Stents, Neurovascular Accessory Devices, Neurovascular Coiling Assist Devices, Neurovascular Embolization Devices and Neurovascular Thrombectomy Devices.
  • Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2015 to 2025.
  • 2017 company share and distribution share data for Interventional Neuroradiology market.
  • Global corporate-level profiles of key companies operating within the United States Interventional Neuroradiology market.
  • Key players covered include Medtronic plc, Penumbra Inc, Stryker Corp and others.
Reasons to buy
  • Develop business strategies by identifying the key market categories poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.


1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Introduction 5
2.1 What Is This Report About? 5
2.2 Interventional Neuroradiology Market Segmentation 5
2.3 Definitions of Markets Covered in the Report 6
3 Interventional Neuroradiology Market, United States 8
3.1 Interventional Neuroradiology Market, United States, Revenue ($m), 2015-2025 8
3.1.1 Neurovascular Accessory Devices Market, United States, Revenue ($m), by Segment, 2015-2025 11
3.1.2 Neurovascular Coiling Assist Devices Market, United States, Revenue ($m), by Segment, 2015-2025 13
3.1.3 Neurovascular Embolization Devices Market, United States, Revenue ($m), by Segment, 2015-2025 15
3.1.4 Neurovascular Thrombectomy Devices Market, United States, Revenue ($m), by Segment, 2015-2025 18
3.2 Interventional Neuroradiology Market, United States, Volume (Units), 2015-2025 20
3.2.1 Neurovascular Accessory Devices Market, United States, Volume (Units), by Segment, 2015-2025 23
3.2.2 Neurovascular Coiling Assist Devices Market, United States, Volume (Units), by Segment, 2015-2025 26
3.2.3 Neurovascular Embolization Devices Market, United States, Volume (Units), by Segment, 2015-2025 29
3.2.4 Neurovascular Thrombectomy Devices Market, United States, Volume (Units), by Segment, 2015-2025 32
3.3 Interventional Neuroradiology Market, United States, Average Price ($), 2015-2025 35
3.4 Interventional Neuroradiology Market, United States, Distribution Share by Revenue ($m), 2017 37
3.5 Interventional Neuroradiology Market, United States, Company Share by Revenue ($m), 2017 38
4 Overview of Key Companies in United States, Interventional Neuroradiology Market 40
4.1 Medtronic Plc 40
4.1.1 Company Overview 40
4.2 Stryker Corp 40
4.2.1 Company Overview 40
4.3 Penumbra Inc 40
4.3.1 Company Overview 40
4.4 Terumo Corp 41
4.4.1 Company Overview 41
4.5 MIZUHO Co Ltd 41
4.5.1 Company Overview 41
4.6 Cerenovus 41
4.6.1 Company Overview 41
5 Interventional Neuroradiology Market Pipeline Products 42
6 Financial Deals Landscape 43
6.1 Equity Offerings 43
6.1.1 AxoGen Raises USD141.4 Million in Public Offering of Shares 43
6.1.2 AxoGen Raises USD41 Million in Public Offering of Shares 45
7 Recent Developments 47
7.1 Corporate Communications 47
7.1.1 Jul 10, 2018: Stryker announces organizational changes 47
7.1.2 Jul 10, 2018: AxoGen Names Lisa N. Colleran As Board Director 47
7.1.3 Jun 22, 2018: Johnson & Johnson Announces Retirement of Group Worldwide Chairman, Sandra E. Peterson 48
7.1.4 Jun 22, 2018: Johnson & Johnson Appoints Senior Leaders to Executive Committee 48
7.1.5 Jun 13, 2018: Prana to Commence Phase 1 Clinical Trial of PBT434 for Treatment of Parkinsonian Diseases 49
7.1.6 Jun 04, 2018: AxoGen Names Kaila Krum Vice President, Investor Relations and Corporate Development 50
7.1.7 May 21, 2018: AxoGen Names Karen Zaderej As Board Chairman 50
7.1.8 Mar 20, 2018: Dominic J. Caruso to Retire as Chief Financial Officer of Johnson & Johnson 51
7.1.9 Dec 14, 2017: Cibiem Appoints William H. Kucheman to the Board of Directors 51
7.1.10 Dec 12, 2017: Stryker announces Mr. Howard E. Cox, Jr. will retire from Board of Directors 52
7.1.11 Nov 01, 2017: New Phase 1/2 Study Data for ALXN1210 as a Potential Future Treatment for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) to Be Presented at American Society of Hematology (ASH) Meeting 52
7.1.12 Oct 18, 2017: AxoGen Receives David J. Gury Company of the Year Award from BioFlorida 53
7.2 Financial Announcements 54
7.2.1 Jul 17, 2018: Johnson & Johnson Reports 2018 Second-Quarter Results 54
7.2.2 May 08, 2018: Penumbra Reports First Quarter 2018 Financial Results 55
7.2.3 Apr 30, 2018: AxoGen Announces 2018 First Quarter Financial Results 56
7.2.4 Apr 26, 2018: Stryker reports first quarter 2018 operating results 57
7.2.5 Apr 17, 2018: Johnson & Johnson Reports 2018 First-Quarter Results 57
7.2.6 Mar 28, 2018: MicroPort Scientific Announces 2017 Annual Results 59
7.2.7 Feb 28, 2018: AxoGen Reports 2017 Fourth Quarter and Full Year Financial Results 61
7.2.8 Feb 27, 2018: Penumbra Reports Fourth Quarter and Full Year 2017 Financial Results 61
7.2.9 Feb 20, 2018: Philips increases Green Revenues to EUR 10.7 billion, 60% of total sales in 2017 62
7.2.10 Jan 30, 2018: Stryker reports 2017 results and 2018 outlook 63
7.2.11 Jan 23, 2018: Johnson & Johnson Reports 2017 Fourth-Quarter Results 64
7.2.12 Jan 22, 2018: Enzo Biochem Announces New Validated Cost-Effective Cervical Cancer Biomarker Detection Test 66
7.2.13 Jan 09, 2018: Stryker provides 2017 preliminary net sales results 68
7.2.14 Jan 08, 2018: AxoGen Preannounces Estimated Fourth Quarter and Full Year 2017 Revenue 69
7.2.15 Nov 07, 2017: Penumbra Reports Third Quarter 2017 Financial Results 69
7.2.16 Nov 01, 2017: AxoGen Reports 2017 Third Quarter Financial Results 70
7.2.17 Oct 26, 2017: Stryker reports third quarter 2017 results 70
7.2.18 Oct 17, 2017: Johnson & Johnson Reports 2017 Third-Quarter Results 72
7.3 Government and Public Interest 73
7.3.1 Jun 05, 2018: Johnson & Johnson Announces Progress Toward Health for Humanity Goals 73
7.4 Product News 74
7.4.1 Nov 20, 2017: AxoGen Advances its Platform for Nerve Repair at Annual Analyst and Investor Day 74
8 Appendix 76
8.1 Research Methodology 77
8.1.1 Coverage 77
8.1.2 Secondary Research 77
8.1.3 Primary Research 78
8.1.4 Market Modeling and Forecasting 79
8.1.5 Company Share Analysis 80
8.1.6 Distribution Share Analysis 81
8.1.7 Benchmarking 81
8.2 GlobalData Consulting 81
8.3 Contact Us 82
8.4 Disclaimer 82
1.1 List of Tables
Table 1: Interventional Neuroradiology Market, United States, Revenue ($m), USD Constant, 2015-2020 9
Table 2: Interventional Neuroradiology Market, United States, Revenue ($m), USD Constant, 2021-2025 10
Table 3: Neurovascular Accessory Devices Market, United States, Revenue ($m), USD Constant, 2015-2020 12
Table 4: Neurovascular Accessory Devices Market, United States, Revenue ($m), USD Constant, 2021-2025 12
Table 5: Neurovascular Coiling Assist Devices Market, United States, Revenue ($m), USD Constant, 2015-2020 14
Table 6: Neurovascular Coiling Assist Devices Market, United States, Revenue ($m), USD Constant, 2021-2025 14
Table 7: Neurovascular Embolization Devices Market, United States, Revenue ($m), USD Constant, 2015-2020 16
Table 8: Neurovascular Embolization Devices Market, United States, Revenue ($m), USD Constant, 2021-2025 17
Table 9: Neurovascular Thrombectomy Devices Market, United States, Revenue ($m), USD Constant, 2015-2020 19
Table 10: Neurovascular Thrombectomy Devices Market, United States, Revenue ($m), USD Constant, 2021-2025 19
Table 11: Interventional Neuroradiology Market, United States, Volume (Units), 2015-2020 21
Table 12: Interventional Neuroradiology Market, United States, Volume (Units), 2021-2025 22
Table 13: Neurovascular Accessory Devices Market, United States, Volume (Units), 2015-2020 24
Table 14: Neurovascular Accessory Devices Market, United States, Volume (Units), 2021-2025 25
Table 15: Neurovascular Coiling Assist Devices Market, United States, Volume (Units), 2015-2020 27
Table 16: Neurovascular Coiling Assist Devices Market, United States, Volume (Units), 2021-2025 28
Table 17: Neurovascular Embolization Devices Market, United States, Volume (Units), 2015-2020 30
Table 18: Neurovascular Embolization Devices Market, United States, Volume (Units), 2021-2025 31
Table 19: Neurovascular Thrombectomy Devices Market, United States, Volume (Units), 2015-2020 33
Table 20: Neurovascular Thrombectomy Devices Market, United States, Volume (Units), 2021-2025 34
Table 21: Interventional Neuroradiology Market, United States, Average Price ($), 2015-2020 35
Table 22: Interventional Neuroradiology Market, United States, Average Price ($), 2021-2025 36
Table 23: Interventional Neuroradiology Market, United States, Distribution Share by Revenue ($m), USD Constant, 2017 37
Table 24: Interventional Neuroradiology Market, United States, Company Share by Revenue ($m), USD Constant, 2017 39
Table 25: Interventional Neuroradiology Market Pipeline Products 42
Table 26: AxoGen Raises USD141.4 Million in Public Offering of Shares 43
Table 27: AxoGen Raises USD41 Million in Public Offering of Shares 45
Table 28: Total Number of Primary Research Participants, Neurology Devices Market, by Country 79
1.2 List of Figures
Figure 1: Interventional Neuroradiology Market, United States, Revenue ($m), USD Constant, 2015-2025 8
Figure 2: Neurovascular Accessory Devices Market, United States, Revenue ($m), USD Constant, 2015-2025 11
Figure 3: Neurovascular Coiling Assist Devices Market, United States, Revenue ($m), USD Constant, 2015-2025 13
Figure 4: Neurovascular Embolization Devices Market, United States, Revenue ($m), USD Constant, 2015-2025 15
Figure 5: Neurovascular Thrombectomy Devices Market, United States, Revenue ($m), USD Constant, 2015-2025 18
Figure 6: Interventional Neuroradiology Market, United States, Volume (Units), 2015-2025 20
Figure 7: Neurovascular Accessory Devices Market, United States, Volume (Units), 2015-2025 23
Figure 8: Neurovascular Coiling Assist Devices Market, United States, Volume (Units), 2015-2025 26
Figure 9: Neurovascular Embolization Devices Market, United States, Volume (Units), 2015-2025 29
Figure 10: Neurovascular Thrombectomy Devices Market, United States, Volume (Units), 2015-2025 32
Figure 11: Interventional Neuroradiology Market, United States, Company Share (%) 2017 38

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report